Lingohr & Partner Asset Management Gmb H Amgen Inc Transaction History

Lingohr & Partner Asset Management Gmb H

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $1.46 Million - $1.64 Million	-8,812 Closed	0 $0
Q4 2017 Jan 19, 2018	BUY	$168.79 - $188.59 $202,548 - $226,308	1,200 Added 15.76%	8,812 $1.53 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $1.27 Million - $1.45 Million	7,612	7,612 $1.33 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Lingohr & Partner Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Lingohr & Partner Asset Management Gmb H with notifications on news.